Nasdaq

Quantum BioPharma's Licensee Celly Nutrition Engages New York Investment Bank for Capital Raise and Potential IPO

BioPharma Ltd. (Quantum BioPharma) announced that its licensee, Celly Nutrition Corporation, is seeking to raise up to $10 million USD and explore an initial public offering on a major U.S. exchange ...
Nasdaq

Quantum Biopharma Licensee Celly Nutrition Retains Leading Audit Firm MNP LLP to Advance Capital Raise and Go-Public Readiness and Changes Name To Unbuzzd Wellness Inc.

TORONTO, May 29, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma”), a biopharmaceutical company dedicated to building a portfolio of ...
Seeking Alpha

Quantum Biopharma Licensee Celly Nutrition Retains Leading New York Investment Bank to Advise on Capital Raise and Possible Initial Public Offering Following Highly Positive ...

TORONTO, Feb. 06, 2025 (GLOBE NEWSWIRE) -- BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) (“Quantum BioPharma (QNTM)” or the “Company ...